medicine

20°

Weather

YnetGlobal Channels

Sites & Sources

more channels

Contact

medicine

The drugs that almost work: why the biggest breakthroughs still fail

As drug developers grapple with partial efficacy and uneven patient response, Tel Aviv-based biotech company Immunai is building an AI-powered immune atlas to explain how therapies work in the body

ynet Global | 04.09.26

Dimer Health raises $13.5 million to expand AI-driven post-discharge care

The Series A round, led by Team8 and Bill Ackman’s Table Management, will help the company expand its physician-led transitional care model across the US as it seeks to reduce readmissions during the critical weeks after hospital discharge

ynet Global | 03.25.26

Etihad Airways plane; airports in the UAE were damaged and suffered heavy disruptions

War disrupts medicine supply routes, raising concerns over cancer treatment delays

War disrupts key Middle East air hubs, forcing rerouting of temperature-sensitive drug shipments; health officials warn prolonged delays could affect cancer treatment supplies

Tzur Gueta | 03.17.26

Graphic abstract (from bottom left, clockwise): Muscle tissue containing mature cells and vascular networks; fat tissue containing blood vessels and lymphatic networks; printing of these flaps; and immediate perfusion of the flap by the host tissue

Technion team develops 3D implant that mimics lost human tissue

The bioengineered flap combines muscle, fat, blood vessels and, for the first time, a lymphatic network in a single structure, offering a potential future alternative for patients with severe tissue loss from burns, injuries or tumor removal

ynet Global | 03.15.26

Gil Hakim, CEO of Matricelf, and Lee Buckler, Vice President, Advanced Therapies Blood Centers of America

Israeli biotech firm Matricelf wins innovation award at San Diego conference

The Ness Ziona-based company was recognized at Advanced Therapies Week 2026 for its personalized spinal cord implant as it prepares to seek approval for human clinical trials

ynet Global | 02.16.26

Used to swallowing pills? smarter ways to take vitamins and medications

New 'delivery systems' protect vitamins and medications and improve absorption, with options including liquids, soft gels, powders and sprays; how do you choose the right one?

Roy Rothenberg | 02.13.26

מימין לשמאל: האלוף במיל' רם רוטברג, מייסד מסע אל האופק, המנטור אלון שחק, אביו של מיכאל פז ומיכאל הזוכה

Combat veteran’s MedTech startup wins top prize for revolutionizing patient intake

Patients enter structured medical information — symptoms, history and background — in advance, while the system delivers a ready clinical summary to doctors before the visit; the project won at OfekTech, the tech accelerator for army and national service alumni of Masa El HaOfek

ynet | 02.10.26

When medical journals become platforms for political messaging: The Lancet and Gaza

Opinion: Recent Gaza coverage by the British medical journal The Lancet highlights a shift from scientific inquiry to moral advocacy, raising concerns about bias, editorial framing and the erosion of academic neutrality in politically charged contexts

Dr. Daniel Radzik | 02.01.26

זוכה הנובל פרופ' יואל מוקיר בדיון בעזיבת רופאים בכנס ScienceAbroad במיאמי

‘Unimaginable gaps in pay’: doctors warn of deepening medical exodus from Israel

Dr. Gabriel Levin, a senior gynecologic oncologist with 320 published papers, left Hadassah for Canada four years ago but will return this summer despite lucrative offers, as a ScienceAbroad conference in Miami highlighted a deepening crisis; Nobel laureate Prof. Joel Mokyr warns Israel is ‘losing the next generation’

Itamar Eichner | 01.19.26

Israeli investor closes $100 million fund focused on next-generation biotech therapies

The new Bio Ventures III fund lifts Arkin Bio’s assets under management above $600 million and will target early-stage biotech companies worldwide developing treatments for cancer, rare diseases and other high unmet medical needs

Maayan Hoffman | 01.17.26

Teva’s billion-dollar bet to treat celiac and vitiligo

Teva is investing up to $500 million in a new antibody it hopes can transform treatment for vitiligo and celiac disease, two autoimmune conditions with limited options and major unmet medical needs

Tzur Gueta | 01.13.26

Teva, Royalty Pharma announce $500M deal to advance autoimmune drug

New partnership aimed at advancing Israeli pharma giant's anti-IL-15 drug for autoimmune diseases; CEO Richard Francis to detail growth strategy and pipeline progress at J.P. Morgan Healthcare Conference on Jan. 13

ynet Global | 01.12.26

Prof. Regina Barzilay at the HealthTech AI Summit 2025

Israel can lead medical AI revolution internationally, says MIT professor

MIT professor Regina Barzilay argues Israel can set the global standard for testing and scaling clinical AI, from regulation and education to implementation inside large health providers

Maayan Hoffman/The Media Line | 01.11.26

Can Israeli medtech grow in the US without relocating? At least one firm plans to help

US-based The Mullings Group opens Israel office, aiming to accelerate Israeli medtech companies’ path to FDA clearance, commercialization and US market scale without forcing founders to relocate

Maayan Hoffman/The Media Line | 12.17.25

גרסיניה. גדלה בעיקר בדרום הודו ובדרום-מזרח אסיה

The tropical fruit gaining attention for blood sugar balance and appetite reduction

Garcinia, a fruit native to South India and Southeast Asia, is said to help balance blood sugar levels and support digestive cleansing

Liora Houbara | 12.05.25

Hot Tags

Today

This Week

This Month

Judicial reform Ahmad al-Sharaa Airstrike Amsterdam Antisemitism Ariel Bibas Benjamin Netanyahu Bitcoin Climate crisis Columbia University

Hot Tags

Today

This Week

This Month

Judicial reform Ahmad al-Sharaa Airstrike Amsterdam Antisemitism Ariel Bibas Benjamin Netanyahu Bitcoin Climate crisis Columbia University